Published on
Apr 2, 2025
Eli Lilly’s experimental drug cuts heart attack risk factor by 94 per cent: What does it mean for Indians?
An experimental drug may be able to tame the sticky and dense cholesterol, called lipoprotein (a) or Lp(a), that quickly clings to arteries and triggers a heart attack. A trial showed that US drug manufacturer Eli Lilly’s lepodisiran could lower levels of …
Source:
The Indian Express
-
Center-left
)
